Sign in
4

Changes in Ownership

BIODESIX INC Filed Acc 0001140361-22-018733

President & CEO sold 13,278 shares at $1.83 ($24,299)

  • President & CEO acquired 44,778 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hutton Scott · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-05-09 Exercise or conversion : show line 1 in the form +44,778 57,144 D
2022-05-10 Sale : show line 2 in the form −13,278 $1.83 $24,299 43,866 D
Open-market sales · 13,278 sh · avg $1.83 · $24,299

Table II: Derivative

2 lines
Date Transaction Shares Underlying Owned after D/I
2022-05-09 Exercise or conversion : show line 3 in the form Restricted Stock Units −12,212 12,212 183,180 D
2022-05-09 Exercise or conversion : show line 4 in the form Restricted Stock Units −32,566 32,566 162,827 D
Loading xslF345X03/form4.xml…